Psychologist’’s Neuropsychotropic Desk Reference

First published in 1999. This comprehensive neuropsychotropic drug reference is designed with prescribing psychologists and psychology students in mind. An accurate and authoritative reference, the Psychologists'' Neuropsychotropic Drug Reference (PNDR) details drug monographs for over 80 different prescription neuropsychotropic drugs available for clinical prescription in North America.

Each neuropsychotropic monograph is clearly and concisely written to reflect essential and important data that are commonly required by prescribing psychologists and psychology students. Thus, whenever possible and appropriate, each monograph includes: a phonetic pronunciation guide; up to five common trade or brand names; pharmacologic or therapeutic classification and subclassification; USDEA schedule designation for abuse potential; recommended dosages; and many other critical details.

The form, style, and content of each monograph has been reviewed by members of an Editorial Advisory Committee of distinguished psychologists. With this quality assurance, this text is certain to become an asset to prescribing psychologists and psychology students as they strive to provide the maximum benefit of neuropsychotropic pharmacotherapy.

First published in 1999. This comprehensive neuropsychotropic drug reference is designed with prescribing psychologists and psychology students in mind. An accurate and authoritative reference, the Psychologists'' Neuropsychotropic Drug Reference (PNDR) details drug monographs for over 80 different prescription neuropsychotropic drugs available for clinical prescription in North America.

Each neuropsychotropic monograph is clearly and concisely written to reflect essential and important data that are commonly required by prescribing psychologists and psychology students. Thus, whenever possible and appropriate, each monograph includes: a phonetic pronunciation guide; up to five common trade or brand names; pharmacologic or therapeutic classification and subclassification; USDEA schedule designation for abuse potential; recommended dosages; and many other critical details.

The form, style, and content of each monograph has been reviewed by members of an Editorial Advisory Committee of distinguished psychologists. With this quality assurance, this text is certain to become an asset to prescribing psychologists and psychology students as they strive to provide the maximum benefit of neuropsychotropic pharmacotherapy.